chr12-64455936-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_013254.4(TBK1):c.66T>C(p.Asn22Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0431 in 1,613,322 control chromosomes in the GnomAD database, including 1,732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 116 hom., cov: 32)
Exomes 𝑓: 0.044 ( 1616 hom. )
Consequence
TBK1
NM_013254.4 synonymous
NM_013254.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.25
Publications
10 publications found
Genes affected
TBK1 (HGNC:11584): (TANK binding kinase 1) The NF-kappa-B (NFKB) complex of proteins is inhibited by I-kappa-B (IKB) proteins, which inactivate NFKB by trapping it in the cytoplasm. Phosphorylation of serine residues on the IKB proteins by IKB kinases marks them for destruction via the ubiquitination pathway, thereby allowing activation and nuclear translocation of the NFKB complex. The protein encoded by this gene is similar to IKB kinases and can mediate NFKB activation in response to certain growth factors. The protein is also an important kinase for antiviral innate immunity response. [provided by RefSeq, Sep 2021]
TBK1 Gene-Disease associations (from GenCC):
- frontotemporal dementia and/or amyotrophic lateral sclerosis 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
- frontotemporal dementia with motor neuron diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autoinflammation with arthritis and vasculitisInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 12-64455936-T-C is Benign according to our data. Variant chr12-64455936-T-C is described in ClinVar as [Benign]. Clinvar id is 475941.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.25 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0503 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBK1 | NM_013254.4 | c.66T>C | p.Asn22Asn | synonymous_variant | Exon 2 of 21 | ENST00000331710.10 | NP_037386.1 | |
TBK1 | XM_005268809.2 | c.66T>C | p.Asn22Asn | synonymous_variant | Exon 2 of 21 | XP_005268866.1 | ||
TBK1 | XM_005268810.2 | c.66T>C | p.Asn22Asn | synonymous_variant | Exon 2 of 21 | XP_005268867.1 | ||
TBK1 | XR_007063071.1 | n.165T>C | non_coding_transcript_exon_variant | Exon 2 of 18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0299 AC: 4551AN: 152216Hom.: 116 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
4551
AN:
152216
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0324 AC: 8119AN: 250762 AF XY: 0.0340 show subpopulations
GnomAD2 exomes
AF:
AC:
8119
AN:
250762
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0445 AC: 64951AN: 1460988Hom.: 1616 Cov.: 30 AF XY: 0.0447 AC XY: 32480AN XY: 726770 show subpopulations
GnomAD4 exome
AF:
AC:
64951
AN:
1460988
Hom.:
Cov.:
30
AF XY:
AC XY:
32480
AN XY:
726770
show subpopulations
African (AFR)
AF:
AC:
205
AN:
33454
American (AMR)
AF:
AC:
733
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
AC:
696
AN:
26104
East Asian (EAS)
AF:
AC:
5
AN:
39684
South Asian (SAS)
AF:
AC:
2910
AN:
86132
European-Finnish (FIN)
AF:
AC:
2026
AN:
53404
Middle Eastern (MID)
AF:
AC:
71
AN:
5762
European-Non Finnish (NFE)
AF:
AC:
56270
AN:
1111464
Other (OTH)
AF:
AC:
2035
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
2761
5523
8284
11046
13807
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0299 AC: 4554AN: 152334Hom.: 116 Cov.: 32 AF XY: 0.0297 AC XY: 2211AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
4554
AN:
152334
Hom.:
Cov.:
32
AF XY:
AC XY:
2211
AN XY:
74500
show subpopulations
African (AFR)
AF:
AC:
343
AN:
41578
American (AMR)
AF:
AC:
260
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
92
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5192
South Asian (SAS)
AF:
AC:
143
AN:
4830
European-Finnish (FIN)
AF:
AC:
437
AN:
10612
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3192
AN:
68024
Other (OTH)
AF:
AC:
43
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
238
476
715
953
1191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
40
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 28, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Glaucoma 1, open angle, P Benign:1
Jul 20, 2016
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.